XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2021   3,171,536    
Beginning Balance at Dec. 31, 2021 $ 184,422,902 $ 80,434,049 $ (15,268,705) $ 119,257,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   66,190    
Issuance of restricted stock grants   $ 11,700,781 (11,700,781)  
Amortization of restricted stock grants 2,248,679   2,248,679  
Issuance of stock grants (in shares)   2,743    
Issuance of stock grants 487,870 $ 487,870    
Issuance of common stock related to 401k plan match (in shares)   108    
Issuance of common stock related to 401k plan match 19,249 $ 19,249    
Issuance of common stock related to employee stock purchase plan (in shares)   2,335    
Issuance of common stock related to employee stock purchase plan 437,346 $ 437,346    
Forfeiture of restricted stock grants (shares)   (1,321)    
Forfeiture of restricted stock grants   $ (244,509) 244,509  
Repurchase of common stock (shares)   (50,104)    
Repurchase of common stock (9,317,661) $ (9,317,661)    
Cash dividends paid (4,818,318)     (4,818,318)
Net income 9,129,952     9,129,952
Ending balance (shares) at Mar. 31, 2022   3,191,487    
Ending Balance at Mar. 31, 2022 182,610,019 $ 83,517,125 (24,476,298) 123,569,192
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2021 17,756,336      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 854,936      
Net subscriptions of consolidated funds 3,837,120      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2022 $ 20,738,520      
Beginning balance (shares) at Dec. 31, 2022 3,010,457 3,010,457    
Beginning Balance at Dec. 31, 2022 $ 163,672,245 $ 51,688,631 (17,011,144) 128,994,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   49,099    
Issuance of restricted stock grants   $ 9,400,986 (9,400,986)  
Amortization of restricted stock grants 2,843,574   2,843,574  
Issuance of stock grants (in shares)   0    
Issuance of stock grants 0 $ 0    
Issuance of common stock related to 401k plan match (in shares)   46    
Issuance of common stock related to 401k plan match 7,843 $ 7,843    
Issuance of common stock related to employee stock purchase plan (in shares)   1,963    
Issuance of common stock related to employee stock purchase plan 323,070 $ 323,070    
Shares withheld related to employee tax withholding (in shares)   (6,121)    
Shares withheld related to employee tax withholding (1,132,507) $ (1,132,507)    
Repurchase of common stock (shares)   (27,706)    
Repurchase of common stock (4,597,931) $ (4,597,931)    
Cash dividends paid (4,576,492)     (4,576,492)
Net income $ 12,707,552     12,707,552
Ending balance (shares) at Mar. 31, 2023 3,027,738 3,027,738    
Ending Balance at Mar. 31, 2023 $ 169,247,354 $ 55,690,092 $ (23,568,556) $ 137,125,818
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2022 14,126,198      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (1,395,495)      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2023 $ 17,332,798